|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
La Jolla Pharmaceutical Co (LJPC) |
|
|
$6.22 0.00 (0.00%) as of 4:30 Thu 8/18
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
27,470,000 |
| Market
Cap: |
170.86(M) |
| Last
Volume: |
2,592,323 |
Avg
Vol: |
2,585,310 |
| 52
Week Range: |
$6.22 - $6.22 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gillespie Deirdre |
President & CEO |
• • – |
2011-05-17 |
4 |
S |
$0.02 |
$1,587 |
D/D |
(99,166) |
0 |
|
- |
|
| Gillespie Deirdre |
President & CEO |
• • – |
2011-05-09 |
4 |
OE |
$0.01 |
$595 |
D/D |
99,166 |
99,166 |
|
- |
|
| Sloan Gail A |
Chief Financial Officer |
• – – |
2011-04-20 |
4 |
S |
$1.00 |
$100 |
D/D |
(100) |
980 |
|
- |
|
| Gillespie Deirdre |
President & CEO |
• • – |
2011-04-19 |
4 |
S |
$0.70 |
$3,063 |
D/D |
(4,376) |
0 |
|
- |
|
| Sloan Gail A |
Chief Financial Officer |
• – – |
2010-06-30 |
4 |
A |
$3.91 |
$547 |
D/D |
140 |
1,080 |
|
- |
|
| Gillespie Deirdre |
President & CEO |
• • – |
2010-05-26 |
4 |
A |
$0.03 |
$13,129 |
D/D |
437,649 |
437,649 |
|
- |
|
| Sloan Gail A |
Chief Financial Officer |
• – – |
2010-05-26 |
4 |
A |
$0.03 |
$2,821 |
D/D |
94,038 |
94,038 |
|
- |
|
| Reinisch Richard |
Individual Investor |
– – – |
2010-03-12 |
4 |
B |
$936.20 |
$18,724 |
D/D |
20 |
20 |
2.44 |
- |
|
| Essex Woodlands Health Ventures Fund Vii Lp |
10% Owner |
– – • |
2009-08-06 |
4 |
S |
$0.18 |
$80,211 |
D/D |
(437,593) |
0 |
|
- |
|
| Sutter Martin P |
Director |
– • – |
2009-08-06 |
4 |
S |
$0.18 |
$151,124 |
I/I |
(824,465) |
0 |
|
- |
|
| Sloan Gail A |
VP of Finance |
• – – |
2009-08-06 |
4 |
S |
$0.19 |
$344 |
D/D |
(1,810) |
0 |
|
- |
|
| Essex Woodlands Health Ventures Fund Vii Lp |
10% Owner |
– – • |
2009-08-05 |
4 |
S |
$0.19 |
$116,630 |
D/D |
(623,026) |
437,593 |
|
- |
|
| Sutter Martin P |
Director |
– • – |
2009-08-05 |
4 |
S |
$0.19 |
$265,069 |
I/I |
(1,415,968) |
437,593 |
|
- |
|
| Sutter Martin P |
Director |
– • – |
2009-07-29 |
4 |
S |
$0.18 |
$20,757 |
D/D |
(112,880) |
0 |
|
- |
|
| Sloan Gail A |
VP of Finance |
• – – |
2009-06-25 |
4 |
S |
$0.18 |
$401 |
I/I |
(2,230) |
0 |
|
- |
|
| Biomarin Pharmaceutical Inc |
10% Owner |
– – • |
2009-06-19 |
4 |
S |
$0.21 |
$524,419 |
D/D |
(2,546,958) |
4,466,387 |
|
- |
|
| Biomarin Pharmaceutical Inc |
10% Owner |
– – • |
2009-06-18 |
4 |
S |
$0.21 |
$460,874 |
D/D |
(2,198,825) |
7,013,345 |
|
- |
|
| Sloan Gail A |
VP of Finance |
• – – |
2009-06-18 |
4 |
S |
$0.20 |
$983 |
D/D |
(4,914) |
1,860 |
|
- |
|
| Biomarin Pharmaceutical Inc |
10% Owner |
– – • |
2009-06-17 |
4 |
S |
$0.22 |
$216,022 |
D/D |
(960,950) |
9,212,170 |
|
- |
|
| Biomarin Pharmaceutical Inc |
10% Owner |
– – • |
2009-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,173,120 |
10,173,120 |
|
- |
|
| Topper James N |
Director |
– • – |
2009-02-26 |
4 |
S |
$0.06 |
$154,927 |
I/I |
(2,756,711) |
0 |
|
- |
|
| Fildes Robert Phd |
Director |
– • – |
2009-02-26 |
4 |
S |
$0.05 |
$869 |
D/D |
(16,612) |
0 |
|
- |
|
| Smith Craig R |
Director |
– • – |
2009-02-26 |
4 |
S |
$0.06 |
$1,518 |
D/D |
(27,200) |
0 |
|
- |
|
| Essex Woodlands Health Ventures Fund Vi L P |
10% Owner |
– – • |
2009-02-26 |
4 |
S |
$0.05 |
$218,608 |
D/D |
(4,236,586) |
1,161,812 |
|
- |
|
| Essex Woodlands Health Ventures Fund Vii Lp |
10% Owner |
– – • |
2009-02-26 |
4 |
S |
$0.05 |
$171,763 |
D/D |
(3,328,747) |
1,060,620 |
|
- |
|
567 Records found
|
|
Page 15 of 23 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
